Cinpanemab
Cinpanemab (BIIB054) is a human-derived monoclonal antibody that binds to α-synuclein. Cinpanemab can be used for the research of Parkinson's disease[1][2].
Product Specifications
CAS Number
[2094516-02-4]
Product Name Alternative
BIIB054; Anti-Alpha-synuclein Reference Antibody (cinpanemab)
UNSPSC
12352203
Target
α-synuclein
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cinpanemab.html
Purity
99.0
Solubility
H2O
Smiles
[Cinpanemab]
Molecular Weight
(146.98 kDa)
References & Citations
[1]Lang AE, et, al. Trial of Cinpanemab in Early Parkinson's Disease. N Engl J Med. 2022 Aug 4;387 (5) :408-420. |[2]Teng JS, et, al. Immunotherapies for Parkinson's Disease: Progression of Clinical Development. CNS Neurol Disord Drug Targets. 2021;20 (9) :802-813.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Isoform
α-synuclein
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15092542 1 Vial
Lentiviral human RUVBL2 shRNA (UAS) - Lentiviral human RUVBL2 shRNA (UAS, GFP) plasmid
Ask
View Details 
MBS1342667-01 0.02 mg (E-Coli)
Recombinant Colwellia psychrerythraea Purine nucleoside phosphorylase DeoD-type (deoD)
Ask
View Details MBS1342667-02 0.1 mg (E-Coli)
Recombinant Colwellia psychrerythraea Purine nucleoside phosphorylase DeoD-type (deoD)
Ask
View Details MBS1342667-03 0.02 mg (Yeast)
Recombinant Colwellia psychrerythraea Purine nucleoside phosphorylase DeoD-type (deoD)
Ask
View Details